1.  Describe the limitations of the current lymphoma classification scheme.

2.  Review recent research purporting to identify genomic subclasses of B-cell lymphomas.

3.  Summarize evidence base to date for targeted therapies in B-cell lymphomas.

Session date: 
06/07/2018 - 12:00pm to 1:00pm CDT
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Leukam, MD, MS